Plant Molecular Biology

, Volume 4, Issue 1, pp 23–30 | Cite as

Interaction of spermidine with viral RNA and its influence on protein synthesis

  • Jadwiga Chroboczek


Addition of spermidine to a cell-free protein synthesizing system from wheat germ programmed with total brome mosaic virus (BMV) RNA resulted in a several-fold stimulation of amino acid incorporation. Increasing the spermidine concentration in the system led to inhibition of the overall protein synthesis, but the production of longer polypeptides was inhibited much more than that of the coat protein (shorter product). Analysis of the products synthesized under direction of BMV RNA 3 (longer product) and RNA 4 (coat protein) revealed that optimal translation of RNA 3 occurred at a much lower concentration of spermidine than that of RNA 4. Binding experiments with radioactive spermidine and BMV RNAs showed that the saturation of spermidine binding is achieved at a lower concentration of spermidine for RNA 3 than for RNA 4, which may suggest that the structure of RNA 4 is more compact than that of RNA 3. Taking into account the binding obtained at a spermidine concentration corresponding to optimal conditions of protein synthesis, it may be concluded that the optimum translation of these two mRNAs occurs when there is a similar level of RNA charge neutralisation, which implies a similar level of RNA structure stabilisation.


translation brome mosaic virus spermidine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tabor CW, Tabor H: Ann Rev Biochem 45:285–306, 1976.PubMedCrossRefGoogle Scholar
  2. 2.
    Cohen SS, McCormick FP: Adv Virus Res 24:331–387, 1979.PubMedCrossRefGoogle Scholar
  3. 3.
    Igarashi K, Takeda Y: Biochim Biophys Acta 213:240–243, 1979.Google Scholar
  4. 4.
    Atkins JF, Lewis JB, Anderson CW, Gesteland RF: J Biol Chem 250:5688–5695, 1975.PubMedGoogle Scholar
  5. 5.
    Hunter TR, Farrell PJ, Jackson RJ, Hunt T: Eur J Biochem 75:149–157, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    Ahlquist P, Luckow V, Kaesberg P: J Mol Biol 153:23–38, 1981.PubMedCrossRefGoogle Scholar
  7. 7.
    Dasgupta R, Kaesberg, P: Nucleic Acid Res 10:703–713, 1982.PubMedGoogle Scholar
  8. 8.
    Lane LC: Adv Virus Res 19:152–220, 1974.Google Scholar
  9. 9.
    Shih D, Kaesberg P: J Mol Biol 103:77–88, 1976.PubMedCrossRefGoogle Scholar
  10. 10.
    Stubbs JD, Kaesberg P: Virology 33:385–397, 1967.PubMedCrossRefGoogle Scholar
  11. 11.
    Dunn JJ: J Biol Chem 251:3807–3814, 1976.PubMedGoogle Scholar
  12. 12.
    Rychlik W, Zagórski W: Acta Biochim Polon 25:129–146, 1978.PubMedGoogle Scholar
  13. 13.
    Chroboczek J, Puchkova L, Zagórski W: J Virol 34:330–335, 1980.PubMedGoogle Scholar
  14. 14.
    Mans RJ, Novelli GD: Arch Biochem Biophys 94:48–53, 1961.CrossRefGoogle Scholar
  15. 15.
    Laemmli UK: Nature 227:680–685, 1970.PubMedCrossRefGoogle Scholar
  16. 16.
    Laskey RA, Mills AD: Eur J Biochem 56:335–341, 1975.PubMedCrossRefGoogle Scholar
  17. 17.
    Schreier AA, Schimmel PR: J Mol Biol 86:601–620, 1974.PubMedCrossRefGoogle Scholar
  18. 18.
    Moruzzi G, Caldarera CM: Arch Biochem Biophys 105:209–210, 1964.PubMedCrossRefGoogle Scholar
  19. 19.
    Abraham AK, Olsnes S, Phil A: FEBS Lett 101:93–96, 1979.PubMedCrossRefGoogle Scholar
  20. 20.
    Takeda Y, Ohnishi T: Biochem Biophys Res Comm 63:611–617, 1975.PubMedCrossRefGoogle Scholar
  21. 21.
    Abraham AK, Pihl A: Eur J Biochem 106:257–262, 1980.PubMedCrossRefGoogle Scholar
  22. 22.
    Takemoto T, Nagamatsu J, Oka T: Biochem Biophys Acta 740:73–79, 1983.PubMedGoogle Scholar
  23. 23.
    Beer SV, Kosuge T: Virology 40:930–938, 1970.PubMedCrossRefGoogle Scholar
  24. 24.
    Okuno T, Furusawa J: Virology 99:218–225, 1979.CrossRefPubMedGoogle Scholar

Copyright information

© Martinus Nijhoff/Dr W. Junk Publishers 1985

Authors and Affiliations

  • Jadwiga Chroboczek
    • 1
  1. 1.European Molecular Biology Laboratory, Grenoble OutstationGrenoble CedexFrance

Personalised recommendations